Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sagopilone dose-finding in metastatic breast cancer
NCT00288249Phase 2Completed
- Sponsor
- Bayer
- Start
- Dec 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of sagopilone in breast cancer, sponsored by Bayer. Started Dec 2005; status: completed.
02
Drugs
sagopilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00288249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00288249.